Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03615326
Brief Title: Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)

First Submitted : July 31, 2018
First Submitted that Met QC Criteria : July 31, 2018
First Posted : August 3, 2018

Last Update Submitted that Met QC Criteria : March 14, 2019
Last Update Posted : March 15, 2019